Related Experiment Video
Updated: Sep 11, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Avicularin induces apoptosis in NSCLC by promoting USP7-mediated degradation of FOXM1
Jiangyue Du1, Kuai Yu2, Jian Zeng3
1Department of General Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Zhejiang, China.
Abstract:
Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide, underscoring the urgent need for novel and effective therapeutic strategies. Avicularin (Avi), a naturally occurring flavonoid, has been shown to reduce cell viability and induce caspase-dependent apoptosis in NSCLC cells, while exhibiting minimal cytotoxicity toward normal bronchial epithelial cells. Mechanistically, Avi selectively decreases FOXM1 protein expression without affecting its mRNA levels, suggesting post-transcriptional regulation. Further investigation revealed that Avi promotes K48-linked polyubiquitination of FOXM1 and disrupts its interaction with the deubiquitinase USP7, thereby destabilizing FOXM1 and enhancing apoptotic signaling. Notably, overexpression of either FOXM1 or USP7 attenuated Avi-induced cytotoxicity. In vivo, Avi markedly inhibited tumor growth in A549 xenograft models without inducing systemic toxicity. Moreover, Avi enhanced the anti-tumor effects of gefitinib, leading to greater apoptosis and reduced cell viability compared to either agent alone. Collectively, these findings demonstrate that Avi exerts potent anti-NSCLC activity by facilitating USP7-dependent degradation of FOXM1 and highlight its potential as both a monotherapy and an adjuvant to EGFR-targeted therapies.
Insights
Avicularin (Avi) effectively targets non-small cell lung cancer (NSCLC) by degrading the FOXM1 protein, offering a potential new treatment. This natural compound shows promise as a standalone therapy or in combination with existing treatments.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Non-small cell lung cancer (NSCLC) is a major global health concern, necessitating innovative therapeutic approaches.
- Avicularin (Avi), a flavonoid, demonstrates anti-cancer properties by reducing NSCLC cell viability and inducing apoptosis with low toxicity to normal cells.
Purpose of the Study:
- To elucidate the mechanism of Avicularin's anti-NSCLC effects.
- To evaluate Avicularin's therapeutic potential as a monotherapy and in combination with gefitinib.
Main Methods:
- Investigated Avicularin's impact on FOXM1 protein and mRNA levels in NSCLC cells.
- Assessed the role of ubiquitination and USP7 in Avicularin's mechanism of action.
- Evaluated Avicularin's efficacy and toxicity in vivo using A549 xenograft models.
- Examined the combined effects of Avicularin and gefitinib in NSCLC treatment.
Main Results:
- Avicularin selectively reduced FOXM1 protein expression via post-transcriptional regulation, promoting its polyubiquitination and degradation by USP7.
- Overexpression of FOXM1 or USP7 counteracted Avicularin's cytotoxic effects.
- Avicularin inhibited tumor growth in vivo without systemic toxicity and enhanced gefitinib's anti-cancer activity.
Conclusions:
- Avicularin exhibits potent anti-NSCLC activity by promoting USP7-dependent degradation of FOXM1.
- Avicularin holds potential as a novel monotherapy or adjuvant treatment for NSCLC, particularly in combination with EGFR-targeted therapies.
More Related Videos
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
The Intrinsic Apoptotic Pathway
Apoptosis
The Extrinsic Apoptotic Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Cancer Cell Migration through Invadopodia